These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22606313)

  • 1. Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
    Bandholtz S; Wichard J; Kühne R; Grötzinger C
    PLoS One; 2012; 7(5):e36948. PubMed ID: 22606313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a peptide ligand for the adhesion GPCR ADGRG2 provides a potent tool to explore receptor biology.
    Sun Y; Zhang D; Ma ML; Lin H; Song Y; Wang J; Ma C; Yu K; An W; Guo S; He D; Yang Z; Xiao P; Hou G; Yu X; Sun JP
    J Biol Chem; 2021; 296():100174. PubMed ID: 33303626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold.
    Woldring DR; Holec PV; Stern LA; Du Y; Hackel BJ
    Biochemistry; 2017 Mar; 56(11):1656-1671. PubMed ID: 28248518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist.
    Dong M; Te JA; Xu X; Wang J; Pinon DI; Storjohann L; Bordner AJ; Miller LJ
    Biochemistry; 2011 Sep; 50(38):8181-92. PubMed ID: 21851058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking of a DOPA-containing peptide ligand into its G protein-coupled receptor.
    Umanah GK; Son C; Ding F; Naider F; Becker JM
    Biochemistry; 2009 Mar; 48(9):2033-44. PubMed ID: 19152328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells.
    English JG; Olsen RHJ; Lansu K; Patel M; White K; Cockrell AS; Singh D; Strachan RT; Wacker D; Roth BL
    Cell; 2019 Jul; 178(3):748-761.e17. PubMed ID: 31280962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.
    Chapter MC; White CM; DeRidder A; Chadwick W; Martin B; Maudsley S
    Pharmacol Ther; 2010 Jan; 125(1):39-54. PubMed ID: 19686775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
    Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational development of a high-affinity secretin receptor antagonist.
    Dong M; Harikumar KG; Raval SR; Milburn JE; Clark C; Alcala-Torano R; Mobarec JC; Reynolds CA; Ghirlanda G; Christopoulos A; Wootten D; Sexton PM; Miller LJ
    Biochem Pharmacol; 2020 Jul; 177():113929. PubMed ID: 32217097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct molecular evolution of detergent-stable G protein-coupled receptors using polymer encapsulated cells.
    Scott DJ; Plückthun A
    J Mol Biol; 2013 Feb; 425(3):662-77. PubMed ID: 23164568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW; Muttenthaler M; Freissmuth M
    Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus-2D: a new approach to the design of targeted combinatorial chemical libraries.
    Cho SJ; Zheng W; Tropsha A
    Pac Symp Biocomput; 1998; ():305-16. PubMed ID: 9697191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico panning for a non-competitive peptide inhibitor.
    Yagi Y; Terada K; Noma T; Ikebukuro K; Sode K
    BMC Bioinformatics; 2007 Jan; 8():11. PubMed ID: 17222344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
    Scott DJ; Rosengren KJ; Bathgate RA
    Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directed evolution of angiotensin II-inhibiting peptides using a microbead display.
    Gan R; Furuzawa S; Kojima T; Kanie K; Kato R; Okochi M; Honda H; Nakano H
    J Biosci Bioeng; 2010 Apr; 109(4):411-7. PubMed ID: 20226387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs.
    Dong S; Rogan SC; Roth BL
    Nat Protoc; 2010 Mar; 5(3):561-73. PubMed ID: 20203671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
    Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
    PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.